Maximum potency requirements favor injection
Track the dose, the symptoms, the timing, and the trend
The sellers fall into three main buckets: International manufacturers who sell peptides at low prices with little or no oversight Research chemical sellers who sell peptides that are labeled with a disclaimer like not for human use Concierge clinics or telehealth platforms that dole out prescriptions for peptides made by compounding pharmacies In practice, the lines between the three categories can blur
The MHRA has issued warnings about unregulated sources of GLP-1 medications, particularly given recent supply shortages
Predictable insurance pathways: Because its been on the market longer, many payors have clearer priorauthorization criteria or grandfathered coverage for Saxenda or its compounded equivalents
Programs may support hydration, recovery, energy, immune function, sleep, body composition, and healthy aging